Cargando…

Endovascular Device Choice and Tools for Recanalization of Medium Vessel Occlusions: Insights From the MeVO FRONTIERS International Survey

Background: Endovascular treatment (EVT) for stroke due to medium vessel occlusion (MeVO) can be technically challenging. Devices and tools are rapidly evolving. We aimed to gain insight into preferences and global perspectives on the usage of endovascular tools in treating MeVOs. Methods: We conduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kashani, Nima, Cimflova, Petra, Ospel, Johanna M., Singh, Nishita, Almekhlafi, Mohammed A., Rempel, Jeremy, Fiehler, Jens, Chen, Michael, Sakai, Nobuyuki, Agid, Ronit, Heran, Manraj, Kappelhof, Manon, Goyal, Mayank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480153/
https://www.ncbi.nlm.nih.gov/pubmed/34603187
http://dx.doi.org/10.3389/fneur.2021.735899
_version_ 1784576416016236544
author Kashani, Nima
Cimflova, Petra
Ospel, Johanna M.
Singh, Nishita
Almekhlafi, Mohammed A.
Rempel, Jeremy
Fiehler, Jens
Chen, Michael
Sakai, Nobuyuki
Agid, Ronit
Heran, Manraj
Kappelhof, Manon
Goyal, Mayank
author_facet Kashani, Nima
Cimflova, Petra
Ospel, Johanna M.
Singh, Nishita
Almekhlafi, Mohammed A.
Rempel, Jeremy
Fiehler, Jens
Chen, Michael
Sakai, Nobuyuki
Agid, Ronit
Heran, Manraj
Kappelhof, Manon
Goyal, Mayank
author_sort Kashani, Nima
collection PubMed
description Background: Endovascular treatment (EVT) for stroke due to medium vessel occlusion (MeVO) can be technically challenging. Devices and tools are rapidly evolving. We aimed to gain insight into preferences and global perspectives on the usage of endovascular tools in treating MeVOs. Methods: We conducted an international survey with seven scenarios of patients presenting A3, M2/3, M3, M3/4, or P2/3 occlusions. Respondents were asked for their preferred first-line endovascular approach, and whether they felt that the appropriate endovascular tools were available to them. Answers were analyzed by occlusion location and geographical region of practice, using multinomial/binary logistic regression. Results: A total of 263 neurointerventionists provided 1836 responses. The first-line preferences of physicians were evenly distributed among stent-retrievers, combined approaches, and aspiration only (33.2, 29.8, and 26.8%, respectively). A3 occlusions were more often treated with stent-retrievers (RR 1.21, 95% CI: 1.07–1.36), while intra-arterial thrombolysis was more often preferred in M3 (RR 2.47, 95% CI: 1.53–3.98) and M3/4 occlusions (RR 7.71, 95% CI: 4.16–14.28) compared to M2/3 occlusions. Respondents who thought appropriate tools are currently not available more often chose stent retrievers alone (RR 2.07; 95% CI: 1.01–4.24) or intra-arterial thrombolysis (RR 3.35, 95% CI: 1.26–8.42). Physicians who stated that they do not have access to optimal tools opted more often not to treat at all (RR 3.41, 95% CI: 1.11–10.49). Stent-retrievers alone were chosen more often and contact aspiration alone less often as a first-line approach in Europe (RR 2.12, 95% CI: 1.38–3.24; and RR 0.49, 95% CI 0.34–0.70, respectively) compared to the United States and Canada. Conclusions: In EVT for MeVO strokes, neurointerventionalists choose a targeted vessel specific first-line approach depending on the occlusion location, region of practice, and availability of the appropriate tools.
format Online
Article
Text
id pubmed-8480153
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84801532021-09-30 Endovascular Device Choice and Tools for Recanalization of Medium Vessel Occlusions: Insights From the MeVO FRONTIERS International Survey Kashani, Nima Cimflova, Petra Ospel, Johanna M. Singh, Nishita Almekhlafi, Mohammed A. Rempel, Jeremy Fiehler, Jens Chen, Michael Sakai, Nobuyuki Agid, Ronit Heran, Manraj Kappelhof, Manon Goyal, Mayank Front Neurol Neurology Background: Endovascular treatment (EVT) for stroke due to medium vessel occlusion (MeVO) can be technically challenging. Devices and tools are rapidly evolving. We aimed to gain insight into preferences and global perspectives on the usage of endovascular tools in treating MeVOs. Methods: We conducted an international survey with seven scenarios of patients presenting A3, M2/3, M3, M3/4, or P2/3 occlusions. Respondents were asked for their preferred first-line endovascular approach, and whether they felt that the appropriate endovascular tools were available to them. Answers were analyzed by occlusion location and geographical region of practice, using multinomial/binary logistic regression. Results: A total of 263 neurointerventionists provided 1836 responses. The first-line preferences of physicians were evenly distributed among stent-retrievers, combined approaches, and aspiration only (33.2, 29.8, and 26.8%, respectively). A3 occlusions were more often treated with stent-retrievers (RR 1.21, 95% CI: 1.07–1.36), while intra-arterial thrombolysis was more often preferred in M3 (RR 2.47, 95% CI: 1.53–3.98) and M3/4 occlusions (RR 7.71, 95% CI: 4.16–14.28) compared to M2/3 occlusions. Respondents who thought appropriate tools are currently not available more often chose stent retrievers alone (RR 2.07; 95% CI: 1.01–4.24) or intra-arterial thrombolysis (RR 3.35, 95% CI: 1.26–8.42). Physicians who stated that they do not have access to optimal tools opted more often not to treat at all (RR 3.41, 95% CI: 1.11–10.49). Stent-retrievers alone were chosen more often and contact aspiration alone less often as a first-line approach in Europe (RR 2.12, 95% CI: 1.38–3.24; and RR 0.49, 95% CI 0.34–0.70, respectively) compared to the United States and Canada. Conclusions: In EVT for MeVO strokes, neurointerventionalists choose a targeted vessel specific first-line approach depending on the occlusion location, region of practice, and availability of the appropriate tools. Frontiers Media S.A. 2021-09-15 /pmc/articles/PMC8480153/ /pubmed/34603187 http://dx.doi.org/10.3389/fneur.2021.735899 Text en Copyright © 2021 Kashani, Cimflova, Ospel, Singh, Almekhlafi, Rempel, Fiehler, Chen, Sakai, Agid, Heran, Kappelhof and Goyal. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Kashani, Nima
Cimflova, Petra
Ospel, Johanna M.
Singh, Nishita
Almekhlafi, Mohammed A.
Rempel, Jeremy
Fiehler, Jens
Chen, Michael
Sakai, Nobuyuki
Agid, Ronit
Heran, Manraj
Kappelhof, Manon
Goyal, Mayank
Endovascular Device Choice and Tools for Recanalization of Medium Vessel Occlusions: Insights From the MeVO FRONTIERS International Survey
title Endovascular Device Choice and Tools for Recanalization of Medium Vessel Occlusions: Insights From the MeVO FRONTIERS International Survey
title_full Endovascular Device Choice and Tools for Recanalization of Medium Vessel Occlusions: Insights From the MeVO FRONTIERS International Survey
title_fullStr Endovascular Device Choice and Tools for Recanalization of Medium Vessel Occlusions: Insights From the MeVO FRONTIERS International Survey
title_full_unstemmed Endovascular Device Choice and Tools for Recanalization of Medium Vessel Occlusions: Insights From the MeVO FRONTIERS International Survey
title_short Endovascular Device Choice and Tools for Recanalization of Medium Vessel Occlusions: Insights From the MeVO FRONTIERS International Survey
title_sort endovascular device choice and tools for recanalization of medium vessel occlusions: insights from the mevo frontiers international survey
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480153/
https://www.ncbi.nlm.nih.gov/pubmed/34603187
http://dx.doi.org/10.3389/fneur.2021.735899
work_keys_str_mv AT kashaninima endovasculardevicechoiceandtoolsforrecanalizationofmediumvesselocclusionsinsightsfromthemevofrontiersinternationalsurvey
AT cimflovapetra endovasculardevicechoiceandtoolsforrecanalizationofmediumvesselocclusionsinsightsfromthemevofrontiersinternationalsurvey
AT ospeljohannam endovasculardevicechoiceandtoolsforrecanalizationofmediumvesselocclusionsinsightsfromthemevofrontiersinternationalsurvey
AT singhnishita endovasculardevicechoiceandtoolsforrecanalizationofmediumvesselocclusionsinsightsfromthemevofrontiersinternationalsurvey
AT almekhlafimohammeda endovasculardevicechoiceandtoolsforrecanalizationofmediumvesselocclusionsinsightsfromthemevofrontiersinternationalsurvey
AT rempeljeremy endovasculardevicechoiceandtoolsforrecanalizationofmediumvesselocclusionsinsightsfromthemevofrontiersinternationalsurvey
AT fiehlerjens endovasculardevicechoiceandtoolsforrecanalizationofmediumvesselocclusionsinsightsfromthemevofrontiersinternationalsurvey
AT chenmichael endovasculardevicechoiceandtoolsforrecanalizationofmediumvesselocclusionsinsightsfromthemevofrontiersinternationalsurvey
AT sakainobuyuki endovasculardevicechoiceandtoolsforrecanalizationofmediumvesselocclusionsinsightsfromthemevofrontiersinternationalsurvey
AT agidronit endovasculardevicechoiceandtoolsforrecanalizationofmediumvesselocclusionsinsightsfromthemevofrontiersinternationalsurvey
AT heranmanraj endovasculardevicechoiceandtoolsforrecanalizationofmediumvesselocclusionsinsightsfromthemevofrontiersinternationalsurvey
AT kappelhofmanon endovasculardevicechoiceandtoolsforrecanalizationofmediumvesselocclusionsinsightsfromthemevofrontiersinternationalsurvey
AT goyalmayank endovasculardevicechoiceandtoolsforrecanalizationofmediumvesselocclusionsinsightsfromthemevofrontiersinternationalsurvey